Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Azukon-M Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Azukon-M Tablet

Diabetol Duo tablets are a dual-action antidiabetic medication, a combination therapy for adult patients with type 2 diabetes. This medication helps regulate blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar monitoring. Continue taking this medication even if feeling well or experiencing controlled blood sugar; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is one element of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation and vomiting may also occur. Learn to recognize and manage hypoglycemia; maintain regular meals and carry a fast-acting glucose source like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possible consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment; it may not be appropriate for all individuals. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is crucial, and your doctor might recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Azukon-M Tablet

No information provided. A rephrased version cannot be created.

Uses of Azukon-M Tablet

Diabetes mellitus type 2

Major Benefits of Azukon-M Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Azukon-M Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Azukon-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Azukon-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Azukon-M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Azukon-M Tablet works:

Azukon-M tablets contain a dual-action formulation of gliclazide and metformin, both agents used in the management of diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Azukon-M Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Azukon-M tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Azukon-M Tablet use are likely incompatible. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Azukon-M tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Azukon-M tablet use. Physician consultation is essential. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Azukon-M tablets, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, Azukon-M tablets are contraindicated in those with severe liver disease.

What if you forget to take Azukon-M Tablet :

Should you forget to take your Azukon-M Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Azukon-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Azukon-M Tablet

Azukon-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Azukon-M is not suitable for type 1 diabetes.
Azukon-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Azukon-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Azukon-M Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, older adults, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Azukon-M immediately and seek immediate medical attention.
Prolonged Azukon-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Azukon-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Azukon-M tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Azukon-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Azukon-M is not suitable for type 1 diabetes.
Azukon-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Azukon-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Azukon-M Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Azukon-M and seek immediate medical attention.
Prolonged Azukon-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Azukon-M Tablets are contraindicated in patients with known hypersensitivity to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Azukon-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Azukon-M Tablet
145
MRP 168
13% off